Alvine Pharmaceuticals

About:

Alvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.

Website: http://www.alvinepharma.com

Top Investors: Flagship Pioneering, Sofinnova Investments, InterWest Partners, Panorama Capital, Black River Asset Management

Description:

Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease.

Total Funding Amount:

$68M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Carlos, California, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)alvinepharma.com

Founders:

Chaitan S. Khosla

Number of Employees:

11-50

Last Funding Date:

2013-01-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai